Other OTC exchange. Sector: Healthcare. Industry: Drug Manufacturers—Specialty & Generic. Location United States, Santa Barbara.

Bloomios, Inc. [BLMSUnited States

2.47USD0.01 (+0.40%)

• At close Sat Oct 01 2022

19,053,150 USD
MARKET CAP
.
PE
-4.995
BETA (5y)
-0.168
EPS

profit

12,250%

for 5 years

profit

2,145%

for 3 years

profit

888%

for 2 years

profit

83%

for 1 year

profit

82%

for this year

About Bloomios, Inc.

Bloomios, Inc. manufactures, markets, and distributes cannabidiol products. The company's product categories include edibles, tinctures, oils, salves, capsules, balms, lotions, creams, beverages, and pet treats. It sells its hemp derived supplements and cosmetic products through wholesale and retail distribution channels. The company was formerly known as XLR Medical Corp. and changed its name to Bloomios, Inc. in April 2021. Bloomios, Inc. was incorporated in 2001 and is headquartered in Santa Barbara, California.

Bloomios, Inc.
https://www.bloomios.com
© 2022 avazzy.com. All rights reserved
Make with 🤎 and ☕ for you!

Investing involves risk, including possible loss of principal.

The strategies discussed are strictly for illustrative and educational purposes and are not a recommendation, offer or solicitation to buy or sell any securities or to adopt any investment strategy. There is no guarantee that any strategies discussed will be effective.

International investing involves risks, including risks related to foreign currency, limited liquidity, less government regulation and the possibility of substantial volatility due to adverse political, economic or other developments. These risks often are heightened for investments in emerging/ developing markets or in concentrations of single countries.